Professor Seng Gee Lim, FRACP, FRCP, FAMS, MD, is Director of Hepatology at the Division of Gastroenterology and Hepatology, National University Health System, Singapore, and was previously Chief of Division.
He is a member of the editorial boards for Liver International, Journal of Viral Hepatitis, Hepatology International, Alimentary Pharmacology and Therapeutics, Lancet Gastroenterology & Hepatology, and Evidence Based Internal Medicine Solutions.
His research includes clinical trials of new treatments for chronic hepatitis B and C, and translational research in viral hepatitis, involving molecular biology and immunology of hepatitis B.

Dr. Gane is Professor of Medicine at the University of Auckland, New Zealand, Hepatologist and Deputy Director of the New Zealand Liver Unit at Auckland City Hospital. 
Dr. Gane trained in hepatology and liver transplantation at the Institute of Liver Studies, King’s College School of Medicine, London, where he completed his thesis on pathogenesis of the newly discovered hepatitis C.  On his return to New Zealand, Dr Gane set up a dedicated Phase I research centre that led the development of the first oral treatments for hepatitis C. He is now focused on developing a finite cure for hepatitis B.
Dr Gane has published over 450 papers in peer-reviewed journals and has received many research awards including the NZHRC Beaven and Liley Medals. 
Dr Gane is the Ministry of Health’s Advisor for viral hepatitis and chairs the oversight committee for the Hepatitis C Elimination Strategy. He also is clinical advisor for the Hepatitis Foundation of New Zealand HepB surveillance programme.

Teresa is a proud Tiwi woman, working and living on Larrakia Country in the Northern Territory. 
Teresa is an Aboriginal Health Practitioner (AHP) Coordinator in Population & Primary Health Care, NT Health and has been an AHP for 20 years. 
Teresa has been a part of the Hepatitis B (HBV) research program for 5 years through her work as an AHP Coordinator. She has been pivotal in the co-design, development and implementation of the Accredited First Nations Workers (FNW) course and is an ongoing course presenter and facilitator as well as an author on the manuscript describing the course development and evaluation. She is an author on a Hepatology review paper “Pathway to Hepatitis B elimination, cure is just the first step” and a member of the Commonwealth commissioned team establishing a roadmap to liver cancer control for Australia. In both settings Teresa has been invited as a cultural and HBV content expert.    
Teresa continues to contribute her cultural knowledge to ensuring that messages are communicated in a culturally safe way. Teresa will also continue to input into the Menzies Infectious Disease Indigenous Reference Group. Teresa is continually striving to improve health outcomes for Aboriginal people. 
What Teresa loves most about her role as an AHP Coordinator is working with AHP’s and Trainees. She strives to be a positive role model to guide the trainees during their learning journey, through to completion and registration, to then go on and be confident, competent Aboriginal Health Practitioners.